HIV-1 Protease and Reverse Transcriptase Mutation Patterns Responsible for Discordances Between Genotypic Drug Resistance Interpretation Algorithms
- 1 May 2003
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 33 (1) , 8-14
- https://doi.org/10.1097/00126334-200305010-00002
Abstract
Several rules-based algorithms have been developed to interpret results of HIV-1 genotypic resistance tests. To assess the concordance of these algorithms and to identify sequences causing interalgorithm discordances, we applied four publicly available algorithms to the sequences of isolates from 2,045 individuals in northern California. Drug resistance interpretations were classified as S for susceptible, I for intermediate, and R for resistant. Of 30,675 interpretations (2,045 sequences × 15 drugs), 4.4% were completely discordant, with at least one algorithm assigning an S and another an R; 29.2% were partially discordant, with at least one algorithm assigning an S and another an I, or at least one algorithm assigning an I and another an R; and 66.4% displayed complete concordance, with all four algorithms assigning the same interpretation. Discordances between nucleoside reverse transcriptase inhibitor interpretations usually resulted from several simple, frequently occurring mutational patterns. Discordances between protease inhibitor interpretations resulted from a larger number of more complex mutation patterns. Discordances between nonnucleoside reverse transcriptase inhibitor interpretations were uncommon and resulted from a small number of individual drug resistance mutations. Determining the clinical significance of these mutation patterns responsible for interalgorithm discordances will improve interalgorithm concordance and the accuracy of genotypic resistance interpretation. Address correspondence and reprint requests to Dr. Robert W. Shafer, Division of Infectious Diseases, Room S-156, Stanford University, Stanford, CA 94301. E-mail: [email protected] Manuscript received January 15, 2003; accepted February 26, 2003. © 2003 Lippincott Williams & Wilkins, Inc.Keywords
This publication has 12 references indexed in Scilit:
- Discrepant results in the interpretation of HIV‐1 drug‐resistance genotypic data among widely used algorithmsHIV Medicine, 2003
- Treatment-Related Factors and Highly Active Antiretroviral Therapy AdherenceJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Phenotypic and Genotypic HIV-1 Drug Resistance Assays Provide Complementary InformationJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trialAIDS, 2002
- A Genotypic Drug Resistance Interpretation Algorithm that Significantly Predicts Therapy Response in HIV-1-Infected PatientsAntiviral Therapy, 2002
- Human Immunodeficiency Virus Type 1 Reverse‐Transcriptase and Protease Subtypes: Classification, Amino Acid Mutation Patterns, and Prevalence in a Northern California Clinic‐Based PopulationThe Journal of Infectious Diseases, 2001
- High Degree of Interlaboratory Reproducibility of Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Sequencing of Plasma Samples from Heavily Treated PatientsJournal of Clinical Microbiology, 2001
- Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European settingAIDS, 2001
- Laboratory Guidelines for the Practical Use of HIV Drug Resistance Tests in Patient Follow-UpAntiviral Therapy, 2001
- Antiretroviral Drug Resistance Testing in Adult HIV-1 InfectionJAMA, 2000